203 related articles for article (PubMed ID: 34124806)
1. Prognostic value of tertiary lymphoid structures in early clinical stage oral tongue squamous cell carcinoma.
Wang C; Huang Z; Zhang M; Xiong G; Chen X; Xie N
J Oral Pathol Med; 2021 Sep; 50(8):776-784. PubMed ID: 34124806
[TBL] [Abstract][Full Text] [Related]
2. Tertiary lymphoid structures associate with improved survival in early oral tongue cancer.
Almangush A; Bello IO; Elseragy A; Hagström J; Haglund C; Kowalski LP; Nieminen P; Coletta RD; Mäkitie AA; Salo T; Leivo I
BMC Cancer; 2022 Oct; 22(1):1108. PubMed ID: 36309667
[TBL] [Abstract][Full Text] [Related]
3. Tumor budding correlates with occult cervical lymph node metastasis and poor prognosis in clinical early-stage tongue squamous cell carcinoma.
Xie N; Wang C; Liu X; Li R; Hou J; Chen X; Huang H
J Oral Pathol Med; 2015 Apr; 44(4):266-72. PubMed ID: 25169851
[TBL] [Abstract][Full Text] [Related]
4. For early-stage oral tongue cancer, depth of invasion and worst pattern of invasion are the strongest pathological predictors for locoregional recurrence and mortality.
Almangush A; Bello IO; Coletta RD; Mäkitie AA; Mäkinen LK; Kauppila JH; Pukkila M; Hagström J; Laranne J; Soini Y; Kosma VM; Koivunen P; Kelner N; Kowalski LP; Grénman R; Leivo I; Läärä E; Salo T
Virchows Arch; 2015 Jul; 467(1):39-46. PubMed ID: 25838076
[TBL] [Abstract][Full Text] [Related]
5. Tumor-stroma ratio can predict lymph-node metastasis in cT1/2N0 oral tongue squamous cell carcinoma independent of tumor budding grade.
Sakai T; Saito Y; Tateishi Y; Yamazawa S; Fukuoka O; Kobayashi K; Omura G; Akashi K; Yoshida M; Ando M; Ebihara Y; Yamasoba T
Int J Clin Oncol; 2022 Dec; 27(12):1818-1827. PubMed ID: 36197545
[TBL] [Abstract][Full Text] [Related]
6. EphA8 is a Prognostic Factor for Oral Tongue Squamous Cell Carcinoma.
Liu L; Wang X; Ge W
Med Sci Monit; 2018 Oct; 24():7213-7222. PubMed ID: 30300334
[TBL] [Abstract][Full Text] [Related]
7. [Postoperative recurrence-related factors of 125 patients with cT1-2N0 squamous cell carcinoma of the oral tongue].
Han JM; Wu GH; Zeng ZY; Chen FJ; Chen WK; Li H; Song M; Sun CZ
Ai Zheng; 2007 Jun; 26(6):661-5. PubMed ID: 17562277
[TBL] [Abstract][Full Text] [Related]
8. Prognostic impact of tumour-stroma ratio in early-stage oral tongue cancers.
Almangush A; Heikkinen I; Bakhti N; Mäkinen LK; Kauppila JH; Pukkila M; Hagström J; Laranne J; Soini Y; Kowalski LP; Grénman R; Haglund C; Mäkitie AA; Coletta RD; Leivo I; Salo T
Histopathology; 2018 Jun; 72(7):1128-1135. PubMed ID: 29427291
[TBL] [Abstract][Full Text] [Related]
9. Cortactin expression in a Norwegian cohort of human papilloma virus negative oral squamous cell carcinomas of the mobile tongue.
Sengüven Toközlü B; Sapkota D; Vallenari EM; Schreurs O; Søland TM
Eur J Oral Sci; 2023 Apr; 131(2):e12925. PubMed ID: 36790139
[TBL] [Abstract][Full Text] [Related]
10. Sentinel lymph node biopsy versus elective neck dissection in patients with cT1-2N0 oral tongue squamous cell carcinoma.
Fan SF; Zeng ZY; Peng HW; Guo ZM; Wang SL; Zhang Q
Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Feb; 117(2):186-90. PubMed ID: 24332157
[TBL] [Abstract][Full Text] [Related]
11. Stromal categorization in early oral tongue cancer.
Almangush A; Bello IO; Heikkinen I; Hagström J; Haglund C; Kowalski LP; Nieminen P; Coletta RD; Mäkitie AA; Salo T; Leivo I
Virchows Arch; 2021 May; 478(5):925-932. PubMed ID: 32955604
[TBL] [Abstract][Full Text] [Related]
12. The systemic inflammation response index predicts the survival of patients with clinical T1-2N0 oral squamous cell carcinoma.
Song F; Cai H; Liao Y; Huang S; Jiang Y; Liang J; Xie N; Hou J
Oral Dis; 2022 Apr; 28(3):600-610. PubMed ID: 33486833
[TBL] [Abstract][Full Text] [Related]
13. Tumour-stroma ratio is a valuable prognostic factor for oral tongue squamous cell carcinoma.
Kang J; Su M; Xu Q; Wang C; Yuan X; Han Z
Oral Dis; 2023 Mar; 29(2):628-638. PubMed ID: 34455659
[TBL] [Abstract][Full Text] [Related]
14. The prognostic role of single cell invasion and nuclear diameter in early oral tongue squamous cell carcinoma.
Almangush A; Hagström J; Haglund C; Kowalski LP; Coletta RD; Mäkitie AA; Salo T; Leivo I
BMC Cancer; 2024 Feb; 24(1):213. PubMed ID: 38360653
[TBL] [Abstract][Full Text] [Related]
15. A New Nomogram for Predicting Overall Survival and Assisting Postoperative Adjuvant Treatment Decision-Making in Stage II Oral Tongue Squamous Cell Carcinoma: A Surveillance, Epidemiology and End Results (SEER) Database Analysis.
Huang F; Xu G; Du H
J Oral Maxillofac Surg; 2021 Oct; 79(10):2147-2154. PubMed ID: 34023287
[TBL] [Abstract][Full Text] [Related]
16. Genetic characteristics of advanced oral tongue squamous cell carcinoma in young patients.
Kim S; Lee C; Kim H; Yoon SO
Oral Oncol; 2023 Sep; 144():106466. PubMed ID: 37393663
[TBL] [Abstract][Full Text] [Related]
17. Validation of the International Tumor Budding Consensus Conference (2016) recommendations in oral tongue squamous cell carcinoma.
Xie N; Yu P; Liu H; Liu X; Hou J; Chen X; Huang H; Wang C
J Oral Pathol Med; 2019 Jul; 48(6):451-458. PubMed ID: 30927486
[TBL] [Abstract][Full Text] [Related]
18. Machine learning-based MRI texture analysis to predict occult lymph node metastasis in early-stage oral tongue squamous cell carcinoma.
Yuan Y; Ren J; Tao X
Eur Radiol; 2021 Sep; 31(9):6429-6437. PubMed ID: 33569617
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of tertiary lymphoid structure and tumour infiltrating lymphocytes in oral squamous cell carcinoma.
Li Q; Liu X; Wang D; Wang Y; Lu H; Wen S; Fang J; Cheng B; Wang Z
Int J Oral Sci; 2020 Sep; 12(1):24. PubMed ID: 32934197
[TBL] [Abstract][Full Text] [Related]
20. Follicle-like tertiary lymphoid structures: A potential biomarker for prognosis and immunotherapy response in patients with laryngeal squamous cell carcinoma.
Liang H; Zhang Z; Guan Z; Zheng S; Lou J; Liu W; Cai Q; Si Y
Front Immunol; 2023; 14():1096220. PubMed ID: 36776859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
